245 related articles for article (PubMed ID: 6235806)
1. The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole.
Walker B; Elmore DT
Biochem J; 1984 Jul; 221(1):277-80. PubMed ID: 6235806
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of trypsin-like serine proteinases by tripeptide arginyl and lysyl chloromethylketones.
Lijnen HR; Uytterhoeven M; Collen D
Thromb Res; 1984 Jun; 34(5):431-7. PubMed ID: 6234678
[TBL] [Abstract][Full Text] [Related]
3. Mechanism-based proteinase inhibitors: a critical review.
Walker B
Biochem Soc Trans; 1986 Apr; 14(2):397-9. PubMed ID: 2940132
[No Abstract] [Full Text] [Related]
4. On the target specificity of plasminogen activator inhibitor 1: the role of heparin, vitronectin, and the reactive site.
Keijer J; Linders M; Wegman JJ; Ehrlich HJ; Mertens K; Pannekoek H
Blood; 1991 Sep; 78(5):1254-61. PubMed ID: 1715220
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the dexamethasone-induced inhibitor of plasminogen activator in HTC hepatoma cells.
Coleman PL; Patel PD; Cwikel BJ; Rafferty UM; Sznycer-Laszuk R; Gelehrter TD
J Biol Chem; 1986 Mar; 261(9):4352-7. PubMed ID: 2936742
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone.
Kettner C; Shaw E
Methods Enzymol; 1981; 80 Pt C():826-42. PubMed ID: 6210829
[No Abstract] [Full Text] [Related]
7. The plasma inhibitors of plasminogen activator, studied by a zymographic technique.
Booth NA; Anderson JA; Bennett B
Thromb Res; 1985 May; 38(3):261-7. PubMed ID: 3161209
[TBL] [Abstract][Full Text] [Related]
8. A cyclopeptidic suicide substrate preferentially inactivates urokinase-type plasminogen activator.
Reboud-Ravaux M; Vilain AC; Boggetto N; Maillard J; Favreau C; Xie J; Mazaleyrat JP; Wakselman M
Biochem Biophys Res Commun; 1991 Jul; 178(1):352-9. PubMed ID: 1829886
[TBL] [Abstract][Full Text] [Related]
9. Amiloride selectively inhibits the urokinase-type plasminogen activator.
Vassalli JD; Belin D
FEBS Lett; 1987 Apr; 214(1):187-91. PubMed ID: 3106085
[TBL] [Abstract][Full Text] [Related]
10. Purification of epidermal plasminogen activator inhibitor.
Hibino T; Izaki S; Izaki M
FEBS Lett; 1986 Nov; 208(2):273-7. PubMed ID: 3096778
[TBL] [Abstract][Full Text] [Related]
11. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
Yamada H; Stephens RW; Nakagawa T; McNicol D
J Biochem; 1988 Dec; 104(6):960-7. PubMed ID: 3149640
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of an inhibitor of plasminogen activator released by rat mammary adenocarcinoma cells.
Grant AJ; Ramshaw IA; Badenoch-Jones P; Eichner RD; Hunt NH
Eur J Biochem; 1986 Feb; 154(3):635-41. PubMed ID: 3081343
[TBL] [Abstract][Full Text] [Related]
13. Aromatic amidines: comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin.
Tidwell RR; Geratz JD; Dubovi EJ
J Med Chem; 1983 Feb; 26(2):294-8. PubMed ID: 6219223
[TBL] [Abstract][Full Text] [Related]
14. An inhibitor of plasminogen activator produced by tumour cell fusion hybrids.
Badenoch-Jones P; Ramshaw IA; Grant A
Aust J Exp Biol Med Sci; 1985 Jun; 63 ( Pt 3)():343-52. PubMed ID: 2933023
[TBL] [Abstract][Full Text] [Related]
15. The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin.
Osterwalder T; Cinelli P; Baici A; Pennella A; Krueger SR; Schrimpf SP; Meins M; Sonderegger P
J Biol Chem; 1998 Jan; 273(4):2312-21. PubMed ID: 9442076
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of the inhibition by plasminogen activator inhibitor 2 of urokinase isolated from human urine and recombinant microorganisms. Further evidence for correct tertiary structure of recombinant urokinase.
Cramer J; Steffens G; Günzler WA; Hess V; Flohé L
Arzneimittelforschung; 1988 Aug; 38(8):1196-8. PubMed ID: 3143371
[TBL] [Abstract][Full Text] [Related]
17. Reaction of a tumour-associated trypsin inhibitor with serine proteinases associated with coagulation and tumour invasion.
Turpeinen U; Koivunen E; Stenman UH
Biochem J; 1988 Sep; 254(3):911-4. PubMed ID: 2461702
[TBL] [Abstract][Full Text] [Related]
18. Effects of netropsin and pentamidine amino analogues on the amidolytic activity of plasmin, trypsin and urokinase.
Pućkowska A; Midura-Nowaczek K; Bruzgo I
Acta Pol Pharm; 2008; 65(2):213-5. PubMed ID: 18666427
[TBL] [Abstract][Full Text] [Related]
19. [Interaction of plasminogen activator of urokinase type with human serum].
Vakulina OP; Popkova EV; Isachenkov VA
Vopr Med Khim; 1988; 34(4):32-6. PubMed ID: 3143185
[TBL] [Abstract][Full Text] [Related]
20. Reaction of thrombin and proteinases of the fibrinolytic system with a mechanism-based inhibitor, 3,4-dihydro-3-benzyl-6-chloromethylcoumarin.
Mor A; Maillard J; Favreau C; Reboud-Ravaux M
Biochim Biophys Acta; 1990 Mar; 1038(1):119-24. PubMed ID: 2138500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
